moderate to severe infections meropenem,
Conditions
Interventions
patients who treat original meropenem
Treatment
original
Sponsors
Siam Pharmaceutical
Buddhachinaraj Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) adult (≥18 years old), 2) had been hospitalized with serious infection, such as lower respiratory tract infection, necrotizing skin/soft tissue infections, nosocomial or health-care associated intraabdominal infections, bacteremia, or sepsis, 3) infection was caused by multi-drug resistant Gram negative bacilli, ESBL-producing Enterobacteriaceae, or mixed anaerobic/aerobic bacteria, and 4) had received either generic meropenem (Mapenem®) or original meropenem
Exclusion criteria
Exclusion criteria: patients with pregnancy or lactation and patients who had hypersensitivity to carbapenems
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to compare clinical outcome of generic and meropenem treatment at day 3, 7, and 14 one year to compare clinical outcome of generic and meropenem treatment at day 3, 7, and 14 | — |
Secondary
| Measure | Time frame |
|---|---|
| to compare safety of generic and meropenem treatment at day 3, 7, and 14 one year to compare safety of generic and meropenem treatment at day 3, 7, and 14 | — |
Countries
Thailand
Contacts
Public ContactSomboon Tansuphasawadikul
Buddhachinnaraj Hospital
Outcome results
None listed